Clinical Case of IVUS-Guided Coronary Artery Stenting in a Patient with Chronic Renal Failure

Introduction. An expanding number of indications for PCI in patients with coronary heart disease and severe concomitant pathology are accompanied by a growing number of patients with chronic renal failure. Contrast-induced nephropathy (CIN) is recognized as a severe complication, aggravating the course of the underlying disease, and, moreover, reducing the life expectancy of the patients. Modern intravascular imaging technologies are widely implemented in real clinical practice of endovascular surgery. In the context of increasing number of PCI performed in patients with severe concomitant pathology, the IVUS-guidance will improve the quality of stenting, and, importantly, lessen the risks of CIN due to the reduction in contrast volume. Materials and methods. The paper presents a clinical case of IVUSguided stenting of the right coronary artery without contrast agent in a patient with chronic kidney disease and the following diagnosis: “Coronary heart disease. Effort angina, class III (dyspnea as anginal equivalent). Balloon angioplasty and stenting of circumflex artery and LAD. Hyperlipidemia 2a. Atherosclerosis of the aorta, brachiocephalic and coronary arteries. Stage 3 hypertension. Controlled Hypertension. Level IV CVD risk. Type 2 diabetes mellitus. Target glycated hemoglobin is less than 7.5%. Grade 2 obesity, exogenous-constitutional. Renal microlithiasis. CKD stage 4 (GFR 29 ml/min/1.73m2). Cerebrovascular disease. Chronic cerebral ischemia.” Results and discussion. In the described clinical case, a complete myocardial revascularization was achieved using IVUS-guidance and minimal amount of contrast agent in a patient with severe CKD. The advantage of minimally invasive endovascular interventions in a complex category of patients, demonstrated by the case, implies expanded possibilities for providing high-tech care to patients with significant limitations in the use of contrast agents due to severe CKD with a high risk of CIN. Conclusion. Today, an increasing number of X-ray operating rooms in Russia are equipped with intravascular technologies, ensuring their wider use. The skills and knowledge in using IVUS imply rare application of contrast agents, thereby lessening the risk of CKD and, as a consequence, improving the prognosis of patients with reduced renal function and high risk of CKD.

1. Alekyan B.G., Grigoryan A.M., Staferov A.V., Karapetyan N.G. Endovascular diagnostics and treatment in the Russian Federation (2020). Russian Journal of Endovascular Surgery. 2021;(S8):S5–248 (In Russ.). DOI: 10.24183/2409-4080-2021-8S-S5-S248

2. Sarnak M.J., Amann K., Bangalore S., Cavalcante J.L., Charytan D.M., Craig J.C., et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(14):1823–38. DOI: 10.1016/j.jacc.2019.08.1017

3. Dunaeva A.R., Shcherbakova A.S., Khafizov T.N., Zagidullin N.Sh. Contrast-induced nephropathy after coronary angiography. Practical medicine. 2014;3(79):35–40 (In Russ.).

4. Holzmann M.J., Siddiqui A.J. Outcome of percutaneous coronary intervention during non-ST-segment-elevation myocardial infarction in elderly patients with chronic kidney disease. J Am Heart Assoc. 2020;9(12):e015084. DOI: 10.1161/JAHA.119.015084

5. Gupta T., Paul N., Kolte D., Harikrishnan P., Khera S., Aronow W.S., et al. Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention. J Am Heart Assoc. 2015;4(6):e002069. DOI: 10.1161/JAHA.115.002069

6. Guo W., Song F., Chen S., Zhang L., Sun G., Liu J., et al. The relationship between hyperuricemia and contrast-induced acute kidney injury undergoing primary percutaneous coronary intervention: secondary analysis protocol for the ATTEMPT RESCIND-1 study. Trials. 2020;21(1):567. DOI: 10.1186/s13063-020-04505-w

7. Sun G., Chen P., Wang K., Li H., Chen S., Liu J., et al. Contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with acute myocardial infarction. Angiology. 2019;70(7):621–6. DOI: 10.1177/0003319718803677

8. Faucon A.L., Bobrie G., Clément O. Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies. Eur J Radiol. 2019;116:231–41. DOI: 10.1016/j.ejrad.2019.03.008

9. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–84. DOI: 10.1159/000339789

10. Rihal C.S., Textor S.C., Grill D.E., Berger P.B., Ting H.H., Best P.J., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259–64. DOI: 10.1161/01.cir.0000016043.87291.33

11. Mehran R., Aymong E.D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–9. DOI: 10.1016/j.jacc.2004.06.068

12. Hoste E.A., De Waele J.J., Gevaert S.A., Uchino S., Kellum J.A. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant. 2010;25(3):747–58. DOI: 10.1093/ndt/gfp389

13. Rufino Hernández J.M., Zamora Rodríguez N., Rodríguez Adanero C., Lorenzo Sellares V., Torres A. Acute renal failure in a tertiary referal hospital, a relevant cause of chronic renal failure and mortality. Nefrologia. 2017;37(6):657–8. DOI: 10.1016/j.nefro.2017.03.008

14. Ikizler T.A., Parikh C.R., Himmelfarb J., Chinchilli V.M., Liu K.D., Coca S.G., et al. A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. Kidney Int. 2021;99(2):456–65. DOI: 10.1016/j.kint.2020.06.032

15. Ronco F., Tarantini G., McCullough P.A. Contrast induced acute kidney injury in interventional cardiology: an update and key guidance for clinicians. Rev Cardiovasc Med. 2020;21(1):9–23. DOI: 10.31083/j.rcm.2020.01.44